Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP421758.RADC51lynJoU761uosqduChn75e0SIlxihRisbL7de0kg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP421758.RADC51lynJoU761uosqduChn75e0SIlxihRisbL7de0kg130_assertion type Assertion NP421758.RADC51lynJoU761uosqduChn75e0SIlxihRisbL7de0kg130_head.
- NP421758.RADC51lynJoU761uosqduChn75e0SIlxihRisbL7de0kg130_assertion description "[Amplification of the topo-II gene was seen in 1/7 (14%) CR and in 3/21 (14%) PD to a taxane-based CT. Topo-II protein was overexpressed in 6/11 (55%) CR and in 2/17 (12%) PD to anthracyclines, while in the control group, overexpression was seen in 5/7 (71%) CR and 8/20 (40%) PD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421758.RADC51lynJoU761uosqduChn75e0SIlxihRisbL7de0kg130_provenance.
- NP421758.RADC51lynJoU761uosqduChn75e0SIlxihRisbL7de0kg130_assertion evidence source_evidence_literature NP421758.RADC51lynJoU761uosqduChn75e0SIlxihRisbL7de0kg130_provenance.
- NP421758.RADC51lynJoU761uosqduChn75e0SIlxihRisbL7de0kg130_assertion SIO_000772 14654958 NP421758.RADC51lynJoU761uosqduChn75e0SIlxihRisbL7de0kg130_provenance.
- NP421758.RADC51lynJoU761uosqduChn75e0SIlxihRisbL7de0kg130_assertion wasDerivedFrom befree-20150227 NP421758.RADC51lynJoU761uosqduChn75e0SIlxihRisbL7de0kg130_provenance.
- NP421758.RADC51lynJoU761uosqduChn75e0SIlxihRisbL7de0kg130_assertion wasGeneratedBy ECO_0000203 NP421758.RADC51lynJoU761uosqduChn75e0SIlxihRisbL7de0kg130_provenance.